Skip to main content

Salbutamol, also known as albuterol. It is a bronchodilator primarily used to treat asthma and chronic obstructive pulmonary disease. Salbutamol was patented in 1966 in Britain and became commercially available in the UK in 1969. It was approved for medical use in the United States in 1982. Salbutamol is found in the World Health Organization’s List of Essential Medicines. It was among the most prescribed medications in the U.S. in 2022 highlighting its widespread use in managing respiratory conditions.

Mechanism of Action of Salbutamol

The mechanism of action of salbutamol is stimulating beta-2 adrenergic receptors in the smooth muscles of the airways. This stimulation causes the muscles to relax, leading to bronchodilation widening the air passages in the lungs. As a result, it makes breathing easier and helps alleviate symptoms like wheezing and shortness of breath. This sudden action is particularly beneficial during asthma attacks or when managing chronic respiratory conditions. Salbutamol is a fast-acting bronchodilator.

It is commonly delivered via inhalers, which are effective for quick relief in asthma attacks or COPD flare-ups. For patients who struggle with inhalers such as young children or those with certain disabilities, salbutamol can also be prescribed in other forms, including tablets, capsules, or syrup. Different forms have specific uses depending on the severity of the condition and the patient’s ability to use inhalers effectively. These alternatives ensure more patients can access the medication they need to manage their respiratory conditions effectively.

Other ways of Administering Salbutamol

Salbutamol can also be administered via nebulizer, which is particularly useful for patients experiencing severe asthma attacks or those who may have difficulty using inhalers. The nebulizer converts the medication into a mist that can be inhaled more easily, providing rapid relief. This method is often used in emergencies or for individuals who need higher doses of the medication. When taken orally, it typically starts working quickly, but the duration of effect is about 4-6 hours. Inhalation methods, such as nebulization or using an inhaler, may have a slightly shorter duration of effect, usually around 3-4 hours. Still, they can provide quicker relief because the medication is delivered directly to the lungs.

Different Names but the Same Medicine

Ventolin, Airomir, Asthalin, Asmatol, Azmasol, SalAir, Salamol, and Respigen are all different brand names for salbutamol, a common bronchodilator used to treat respiratory conditions like asthma and COPD. Each brand may have slight variations in formulation, but they all contain salbutamol as the active ingredient. When salbutamol is taken, the body responds in several significant ways, particularly affecting the respiratory system via bronchodilation, reduced airway resistance, improved pulmonary function, reduced mucus secretion, and inhibited inflammatory response.

These responses make salbutamol effective for managing acute symptoms of asthma and other respiratory conditions. Salbutamol and salbutamol sulfate refer to the same active medication, with the distinction mainly being that salbutamol is the name of the active ingredient, while salbutamol sulfate is the specific salt form used in pharmaceutical preparations. Salbutamol is indeed the active ingredient in salbutamol sulfate, and the excipients can vary by formulation. Checking the product’s package insert is the best way to get detailed information about the specific excipients used. Excipients can vary depending on the specific product and its form. Common excipients might include Propellants (in metered-dose inhalers), Lactose (as a filler in tablets), Sodium chloride (to adjust osmolarity), Citric acid (as a pH adjuster), Preservatives (in some liquid formulations), etc.

Disclaimer:

As a service to our readers, MVS Pharma GmbH publishing provides access to our library of archived content — in our blogPlease note the date of the last review or update on all articles. No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

MVS Pharma GmbH will soon be launching an omega-3 dietary supplement onto the European market that has been developed for the highest quality standards in terms of oxidation avoidance and therefore greatest bioavailability. In addition, in vitro studies are currently underway at the University of Ulm, in which Professor Dr. Rüdiger Groß tested a patented mouth and nose spray (Virudol) that can eliminate various flu viruses based on natural substances. In addition, MVS has a wholesale license and has specialized in sourcing much-needed medicines such as Amoxicillin, Salbutamol, etc. from India through its local branch with a focus on local quality and safety testing, compliance with international GMP regulations and the highest quality level of user security (examples of local language brochures, identical units of measurement, batch control and full tracking, etc.).

 

Senior Pharmacist Riya Jayapal Roja

Senior Pharmacist at MVS Pharma GmbH. Riya is in charge of detailed analysis of product formulation, quality checks, market research and advising the purchase department at MVS Pharma GmbH. She also conducts valuable research, and writes health-related articles.